What is the Mankind Pharma IPO listing date?
Mankind Pharma IPO listed on May 9, 2023 on NSE and BSE at ₹1,300, a 20.4% gain over the issue price of ₹1,080.
What was the Mankind Pharma IPO GMP?
The grey market premium (GMP) for Mankind Pharma IPO was ₹220 at closing, implying a 20.4% listing gain. GMP remained steady at ₹130-₹220 throughout the subscription period, correctly signalling a positive listing.
What was Mankind Pharma IPO subscription status?
Mankind Pharma IPO was subscribed 15.32x overall. QIB subscription was 22.58x, NII (HNI) was 13.13x, and retail was 8.59x.
What brands does Mankind Pharma own?
Mankind Pharma owns Prega News (pregnancy test kits), Manforce (contraceptives), Gas-O-Fast (antacid), AcneStar, and Unwanted-72. It is India's fourth largest pharma company by domestic sales, with strong presence in Tier 2-3 cities.
What is the allotment date for Mankind Pharma IPO?
The allotment date for Mankind Pharma IPO was May 3, 2023. Refunds were processed on May 5, 2023 and demat credit was on May 8, 2023.
Was Mankind Pharma IPO an OFS?
Yes, Mankind Pharma IPO was 100% OFS (offer for sale) by the Juneja promoter family. No fresh capital was raised for the company.
Who was the registrar for Mankind Pharma IPO?
Link Intime India was the registrar for Mankind Pharma IPO. To check allotment status, visit linkintime.co.in, select Mankind Pharma IPO, and enter your PAN or application number.